Media Mentions11.3.22
Supreme Court unlikely to take up Coreg skinny label feud after Teva's $235M loss to GSK, lawyer says

Ron Cahill was quoted in a Fierce Pharma article, "Supreme Court unlikely to take up Coreg skinny label feud after Teva's $235M loss to GSK, lawyer says."
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
